[Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005292:Ferricyanides / Q000627:therapeutic use*; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009599:Nitroprusside / Q000008:administration & dosage / Q000627:therapeutic use*; D011224:Prazosin / Q000008:administration & dosage / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
D005292:Ferricyanides; D011799:Quinazolines; D009599:Nitroprusside; D011224:Prazosin
Terapia vasodilatatrice della insufficienza cardiaca congestizia: confronto degli effetti emodinamici dopo somministrazione di nitroprussiato di sodio e prazosin.